Dissemin is shutting down on January 1st, 2025

Published in

Bentham Science Publishers, Endocrine, Metabolic & Immune Disorders - Drug Targets, 8(22), p. 798-806, 2022

DOI: 10.2174/1871530322666220328122300

Links

Tools

Export citation

Search in Google Scholar

Endocrine Disruptors and Obesity: An Overview

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Obesity is a growing pandemic. Endocrine-disrupting chemicals are widespread in the en-vironment. In this perspective, the authors examine the issue related to the exposure to several chem-icals with endocrine-disrupting properties as promoting factors to obesity. Data show that Phthalates, Bisphenol compounds, Persistent Organic Pollutants (POPs), solvents, and personal care products can modify metabolic properties in a dose-response and sex-specific manner. Phthalates and bi-sphenol compounds increase body mass index, waist circumference, waist to height ratio, and the sum of skinfold thicknesses in women and not in men. Low-dose exposure to Persistent Organic Pol-lutants is strongly associated with increased body mass index in men and decreased this parameter in women. The mechanism through which these compounds act on anthropometric parameters is not entirely understood. Several studies suggest a possible interference in gonadotropin secretion and the thyroid axis. These inspire a decrease in both total and free testosterone levels in men and FT3 and FT4 levels in women, particularly after a pregnancy. The impact of endocrine disruptor chemicals on adipose tissue inflammation and future cardio-metabolic disorders remains to be elucidated. There-fore, studies involving both healthy and obese individuals are needed to unambiguously confirm re-sults from in vitro and animal models.